ACKGROUND: Cisplatin (CP) as an anticancer drug may affect the plasma glucose level while diabetic subjects are protected against CP-induced nephrotoxicity. In the current study, the role of dextrose hydration during CP therapy on CP-induced nephrotoxicity was evaluated.
Introduction
Cisplatin (CP) has been used widely in clinic for solid tumor chemotherapy; however one of the side effects of CP is nephrotoxicity which limits its clinical use. The CP-induced nephrotoxicity was reported to be gender related (1) (2) (3) (4) , and antioxidants supplements may attenuate the side effect of nephrotoxicity (1, (5) (6) (7) (8) (9) . The experimental findings also indicated that the sex hormone, estrogen, affects the CPinduced nephrotoxicity. (10) (11) (12) (13) In addition, this female sex hormone may promote CP-induced nephrotoxicity (11) or limit the protective effect of antioxidant against CP-induced kidney injury (13) .
CP may decrease glucose uptake in ovarian cancer cell, and it disappears the membrane localization of glucose transporter 1. (14) In addition, CP itself may induce hyperglycemia and glucose intolerance (15) , and this impairment maybe related to insulin secretion deficiency. (16) Previously, it was reported that in diabetic animals were protected against CP-induced nephrotoxicity. (17) (18) (19) (20) Diabetes disturbs the active transport of proximal tubule and reduce CP accumulation in the tubule (21) , therefore, it protects the kidney against CP-induced nephrotoxicity. However, among the factors affecting CP-induced nephrotoxicity, the role of glucose is not well clear.
Usually, based on the treatment guideline, the candidate patients for CP therapy must be hydrated during CP administration. (22) If hyperglycemia is the main cause of kidney protection against CP-induced nephrotoxicity in diabetic subjects, it is expected that the patients who hydrated with high glucose solution (instead saline) would be protected against CP-induced nephrotoxicity. On the other hand, practically it is observed that many of the patients who are candidate for CP therapy have an appetite to eat cookie or high sweet diets during the CP administration time in the hospital.
Collectively, there are 2 facts. First, CP administration is accompanied with side effect of nephrotoxicity gender dependently.(1-4) Secondly, the diabetic subjects are protected against CP-induced nephrotoxicity. (17) (18) (19) (20) One explanation for this difference is related to the dose of glucose concentration which is different in normal and diabetic conditions. Therefore, one question was raised, is high dose of glucose uptake during CP therapy could protect the kidney against CP-induced nephrotoxicity or not, and what is the role of gender? In order to answer these questions, male and female rats were subjected to hydrate with different doses of dextrose solution during CP therapy, and they were compared with control group.
Methods
The protocol of this research was considered and approved by the Ethics Committee of Isfahan University of Medical Sciences (IR.MUI.REC.1397.2.055).
Drugs
The CP and dextrose were purchased from Malan (Athens, Greece) and Shahid Ghazi Pharmaceutical Co (Tabriz, Iran).
Experimental Groups
This research was conducted on 69 male and female Wistar rats in 12 groups (6 groups of male and 6 groups of female rats). Group 1 and 7 (vehicle groups) were consisted of 5 male and 6 female rats. Eleven rats were subjected to 3 treatments. The first treatment of vehicle (saline, 15 mL/ kg, intraperitoneally) was applied at the beginning of experiment. The second treatment of vehicle (0.5-1 mL/rat) was applied 60 min post the first treatment. Finally, the third treatment of vehicle (saline, 15 mL/kg, intraperitoneally) was applied 60 min post the second treatment.
Group 2 and 8 were the dextrose 10% groups, which were consisted of 5 male and 6 female rats. They received the same regimen as groups 1 and 7, except they were given dextrose 10% (15 mL/kg, intraperitoneally) instead of vehicle (saline) for the first and third treatments.
Group 3 and 9, or known as CP groups, were consisted of 5 male and 6 female rats, which received the same regimen as group 1 and 7, except they were given CP (7.5 mg/kg, intraperitoneally), instead of vehicle (saline) for the second treatment.
Group 4 and 10, the CP + dextrose 2% groups, were consisted of 6 male and 6 female. These 12 rats were also subjected to 3 treatments. The first treatment of dextrose 2% (15 mL/kg, intraperitoneally) was applied at the beginning of experiment. The second treatment of CP (7.5 mg/kg, intraperitoneally) was applied 60 min post the first treatment, and the third treatment of dextrose 2% (15 mL/ kg, intraperitoneally) was applied 60 min post the second treatment.
Group 5 and 11, the CP + dextrose 10% groups, were consisted of 6 male and 6 female rats, which were treated just like groups 4 and 10, except they received 15 mL/kg of dextrose 10% instead of dextrose 2% for the first and third treatments.
Group 6 and 12, CP + dextrose 20% groups, were consisted of 5 male and 6 female rats, which were treated as groups 4 and 10, except they received 15 mL/kg of dextrose 20% instead dextrose 2% for the first and third treatments.
Survival Time Determination
The animals were kept in standard cages with free access to water and food. All the animals were observed continually (3-4 times a day) and weighted in the first and 8 th days of experiment. The mortality rate for each animal group was recorded daily.
Urine, Blood and Kidney Tissue Samples Collections
The remained survived animals until the 8 th day were subjected to place in metabolic cages for 5 hours before sacrifice for urine collection. The total amount of urine collection in each animal was measured precisely and reported as microliter per minute per gram kidney tissue. Then, blood samples were obtained and the animals sacrificed humanly. The kidneys were removed rapidly and weighted. The tissues were fixed in formalin 10% to perform histological investigation using hematoxylin and eosin (H&E) staining. The kidney tissue damage score (KTDS) was recorded by two pathologist who were blinded to study protocol. The score was assigned from 1 to 4 based on intensity of tissue damage while zero was considered as normal.
Biochemical Parameters Measurements
The levels of blood urea nitrogen (BUN) and creatinine (Cr), were determined using quantitative diagnostic kits (Pars Azmoon, Tehran, Iran). The malondialdehyde (MDA) levels in the serum and kidney tissue were measured by the manual method. The serum and kidney tissue levels of nitrite (stable nitric oxide (NO) metabolite) were measured using Griess method. The levels of sodium (Na) in serum and urine were determined using flame photometer assay.
Kidney Function Parameters Measurements
The Cr clearance (ClCr) was determined using clearance formula as; ClCr = UF * UCr/ PCr where UF, UCr and PCr were assigned for urine flow rate, urine Cr concentration and serum level of Cr. The Na filtration rates (FNa) and Na excretion rate (ENa) were calculated by [ClCr x serum concentration of Na] and [UF x urine concentration of Na] respectively.
Statistical Analysis
Data were reported as mean±SEM. The ANOVA and Dunnet test as post hoc were applied for comparison between the groups. The survival time and KTDS between the groups were compared by non-parametric tests of KruskalWallis and Mann-Whitney U. The statistical p-value was significant when it was less than 0.05.
Animal's Survival Time
The data for animal's survival time are tabulated in Table 1 . The entire male (survival time = 4.8±0.4 days) and female (survival time = 4.0±0.0 days) animals treated with CP + extrose 20% expired during the experiment and no animals were survived for the last day of experiment (sacrifice day). Therefore no data were reported here for these groups. No animals were died in the control groups of male (groups 1-3) and female (groups 7-9) rats. However, 3 male and 2 female animals that treated with CP + dextrose 2%-10%
Results
were expired during the experiment before sacrifice day (Table 1) .
Body and Kidney weights
The body weight percentage change (∆W%) and normalized kidney weight (KW) in vehicle, dextrose 10% or CP alone (male's group 1-3 and female's group 7-9) treated groups were compared to determine the effect CP or dextrose alone administration (Table 2A ). The results indicated that CP increased the absolute ∆W and KW significantly (p<0.05) in both genders.
The animals treated with CP alone also were compared with the animals co-treated with CP and dextrose ( Figure  1A ). Co-administration of CP and dextrose did not attenuate the KW when compared with CP alone treated group ( Figure  1A ). Instead, in the female rats, co-administration of CP and dextrose 10% not only attenuate the KW but also increased the KW (1.36±0.16 g) significantly when compared with CP alone (0.94±0.04 g) treated group (p<0.05) ( Figure 1A ).
Biochemical Parameters
The serum levels of BUN, Cr and BUN/Cr ratio in vehicle, dextrose 10% or CP alone treated groups (male's group 1-3 and female's group 7-9) were compared to determine the effect CP or dextrose alone administration (Table 2B ). The results indicated that CP increased the above parameters (except the serum level of Cr in female) significantly (p<0.05).
The animals treated with CP alone also were compared with the animals co-treated with CP and dextrose ( Figure  1B ). Co-treatment of CP and dextrose did not attenuate the serum level of BUN, Cr and BUN/Cr ratio in male. However, in female rats, the co-administration of CP and dextrose 10% increased the serum level of BUN The serum and kidney tissue levels of nitrite and MDA in vehicle, dextrose 10% or CP alone treated groups (male's group 1-3 and female's group 7-9) also were compared to determine the effect CP or dextrose alone administration (Table 2C ). The results indicated that CP altered the serum and kidney levels of nitrite and the serum level of MDA significantly (p<0.05) in male groups.
The animals treated with CP alone also were compared with the animals co-treated with CP and dextrose ( Figure  1C) . The serum and kidney tissue levels of MDA in male rats were not different statistically between CP alone treated Indones Biomed J. 2019; 11 (2) 
The effects of dextrose 10% and CP administration against vehicle on body and kidney weight (A), serum levels of BUN, Cr, BUN/Cr ratio (B), and serum and kidney levels of nitrite and MDA (C).
The p-value was obtained by ANOVA, and the star (*) indicates significant differences (p<0.05) from vehicle group using Dunnet test. CP: cisplatin, ∆W; weight change, KW: kidney weight, BUN: blood urea nitrogen, Cr: creatinine.
group and co-treated of CP and dextrose groups. However, in female rats the serum and kidney tissues levels of MDA were decreased in co-treated of CP and dextrose groups when compared with CP alone treated rats ( Figure 1C) The serum levels of nitrite decreased (significantly), and the tissue levels of nitrite were increased (insignificantly) in co-treated of CP and dextrose male rats when compared with CP alone treated group ( Figure 1C) . Such observation was not seen in female rats but co-treatment of CP and dextrose 2% increased the kidney tissue level of nitrite statistically (p<0.05).
Kidney Function Parameters
The UF, ClCr, FNa, ENa and Na excretion fraction (%) in vehicle, dextrose 10% or CP alone treated groups (male's group 1-3 and female's group 7-9) were compared to determine the effect CP or dextrose alone administration (Table 3A) . The ClCr and FNa in both genders, ENa in female and Na excretion fraction (%) in male were significantly different between CP treated rats and vehicle treated group (p<0.05).
The animals treated with CP alone also were compared with the animals co-treated with CP and dextrose ( Figure  2) . The results of renal function markers; UF, ClCr, FNa, ENa and percentage of Na excretion fraction are presented in Figure 2 . They are indicated that co-administration of CP and dextrose compared to CP alone did not alter the renal function markers neither in male nor in female rats. Actually in female, all the above markers in co-treated group of CP Indones Biomed J. 2019; 11 (2) and nitrite for survived animals in the experimental groups. The CP, CP+DS2% and CP+DS10% indicate the groups treated with cisplatin, cisplatin plus dextrose 2% and cisplatin plus dextrose 10%, respectively. The p-value was obtained by ANOVA. The star (*) indicates significant differences (p<0.05) from CP using Dunnet test.
and dextrose 10% were decreased when compared with CP alone treated group, however these change were not statistically significant (Figure 2 ).
Kidney Histology Findings
The KTDS in vehicle, dextrose 10% or CP alone treated groups (male's group 1-3 and female's group 7-9) were compared to determine the effect CP or dextrose alone administration (Table 3B ). The results indicated that CP increased the KTDS significantly (p<0.05) in both genders.
The animals treated with CP alone also were compared with the animals co-treated with CP and dextrose ( Figure  3 ). The KTDS did not alter in co-treated of CP and dextrose male rats compared to CP alone treated group, however in female rats, the KTDS was increased significantly in cotreated with CP and dextrose 10% group compared to CP alone treated group (3.3±0.2 vs. 2.3±0.2; p<0.05). More tubular tissue damage was observed in female rats treated with CP and dextrose 10% compared to the CP alone treated animals. 
A B
The p-value in part A was obtained by ANOVA, and the star (*) indicates significant differences (p<0.05) from vehicle group using Dunnet test. The p-value in part B was obtained Kruskal-Wallis, and the star (*) indicates significant differences (p<0.05) from vehicle group using Mann-Whitney U test. CP: cisplatin; UF: urine flow rate; ClCr: Creatinine clearance; FNa: sodium filtration rate; ENa: sodium excretion rate; KTDS: kidney tissue damage score. Figure 2 . The urine flow (UF), creatinine clearance (ClCr), sodium (Na) filtration rate (FNa), Na excretion rate (ENa) and percentage of Na excretion fraction in cisplatin, cisplatin plus dextrose 2% and cisplatin plus dextrose 10% treated groups, respectively. The p-value was obtained by ANOVA. The star (*) indicates significant differences (p<0.05) from CP using Dunnet test. CP: cisplatin; DS: dextrose. The unit for UF=µL/mim/g tissue, ClCr=µL/mim/g tissue, ENa=µmol/mim/g tissue, FNa=µmol/mim/g tissue; FNa fraction=%.
Discussion
The purpose of this study was to determine the possible protective role of dextrose hydration during CP therapy against CP induced nephrotoxicity. Our hypothesis was rejected while dextrose promoted CP-induced nephrotoxicity, and the major findings of this research revealed that dehydration with dextrose during CP therapy acts as risk factor to promote kidney toxicity.
No animals were survived when dextrose 20% was accompanied with CP, possibly due to toxic effect of high dose of dextrose. The animals weight loss was observed in the all survived animals treated with CP which was expected as observed in other studies. (1) (2) (3) (4) In addition the elevations of the serum levels of BUN and Cr and KW are associated with increase of kidney damage after CP administration (4), and our results indicated that dextrose 10% elevated these parameters in female gender. It seems these alterations are related to the decrease of ClCr (or glomerular filtration rate) in female rats treated with CP and dextrose 10% ( Figure  2 ). These findings in female rats also are in agreement with pathology data and KTDS (Figure 3) .
It has been proposed that diabetes protects the kidneys against CP administration (18) (19) (20) , and the degree of protection depends on degree of hyperglycemia. Previous study reported that the diabetic state could protect that kidney against CP-induced nephrotoxicity, and the kidney toxicity would be higher if the hyperglycemia was corrected by insulin. (20) The vacuolated cells, tubular dilation and necrosis-induced by CP administration in rat. However these tissue damages were attenuated in diabetic state. (20) One mechanism is related to kidney drug accumulation, because in diabetic state, the reduction of platinum accumulation in the kidney is occured. (23) One study demonstrated that hyperglaycemia reduction by insulin treatment in diabetic rats may not protect the kidney against CP-induced nephrotoxicity.(18) Therefore, it seems that an interaction between glucose concentration and CP exists as the membrane localization of glucose transporter 1 may disappear by CP therapy. (14) In our study, it seems that the high dose of dextrose administration was toxic in CP treated rats, and possibly administration of dextrose induces insulin secretion in non-diabetics rats which causes platinium accumulation in renal cortex.(18) Therefore, accumulation of CP in kidney promotes nephrotoxicity as shown by increase in kidney weight and Cr level increase in dextrose treated rats. Other study demonstrated that the serum level of insulin was increased after 3 days post CP injection, and CP-induced hyperglycemia and glucosuria precede CP induced acute renal failure. (24) Conclusion Collectively, our data not only did not support the nephroprotective role of dextrose hydration during CP therapy but also indicated that dextrose diets during CP therapy act as risk factor to promote CP-induced nephrotoxicity in female rats. Further studies are needed to find the exact mechanism.
